Imaging of ONOO- fluctuations during drug-induced liver/kidney injury in vitro and in vivo a dicyanoisophorone-based NIR fluorescent probe with large Stokes shift
Abstract
Current clinical indicators for assessing liver/kidney injury are functional rather than injury indicators, which may cause some delays in the diagnosis of drug-induced liver injury (DILI) and kidney injury (DIKI). Therefore, the development of noninvasive and real-time methods to effective diagnosis of DILI/DIKI are of great benefit to their clinical management. Herein, we constructed a dicyanoisophorone-based near-infrared (NIR) fluorescent probe (PNDP), up addition of ONOO-, the probe exhibits 111.4-fold fluorescence enhancement at 665 nm with a large Stokes shift of 175 nm, as well as excellent selectivity, strong anti-interference capability, and a low limit of detection (118.9 nmol/L). More significantly, PNDP has been successfully employed for the sensitive detection of ONOO- in living cells and DILI/DIKI mice models, the in vitro and in vivo bioimaging experiments demonstrated that PNDP has greater versatility and promising potential to be used as a diagnostic agent for the diagnosis of drug-induced hepatotoxicity and nephrotoxicity by monitoring ONOO- fluctuations.
- This article is part of the themed collection: Materials Chemistry of Fluorescence Bioimaging